ZA948667B - A process for the preparation of a virus inactivated fraction containing factor VIII by means of chromatographic methods - Google Patents

A process for the preparation of a virus inactivated fraction containing factor VIII by means of chromatographic methods

Info

Publication number
ZA948667B
ZA948667B ZA948667A ZA948667A ZA948667B ZA 948667 B ZA948667 B ZA 948667B ZA 948667 A ZA948667 A ZA 948667A ZA 948667 A ZA948667 A ZA 948667A ZA 948667 B ZA948667 B ZA 948667B
Authority
ZA
South Africa
Prior art keywords
factor viii
chromatographic methods
preparation
fraction containing
containing factor
Prior art date
Application number
ZA948667A
Other languages
English (en)
Inventor
Ales Strancar
Monika Andrea Stadler
Djuro Josic
Original Assignee
Octapharma A G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6501733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA948667(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma A G filed Critical Octapharma A G
Publication of ZA948667B publication Critical patent/ZA948667B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA948667A 1993-11-04 1994-11-03 A process for the preparation of a virus inactivated fraction containing factor VIII by means of chromatographic methods ZA948667B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4337573A DE4337573C1 (de) 1993-11-04 1993-11-04 Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden

Publications (1)

Publication Number Publication Date
ZA948667B true ZA948667B (en) 1995-07-07

Family

ID=6501733

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA948667A ZA948667B (en) 1993-11-04 1994-11-03 A process for the preparation of a virus inactivated fraction containing factor VIII by means of chromatographic methods

Country Status (21)

Country Link
EP (1) EP0726907B1 (pl)
JP (1) JP3739788B2 (pl)
KR (1) KR960705841A (pl)
CN (1) CN1109045C (pl)
AT (1) ATE228533T1 (pl)
AU (1) AU687451B2 (pl)
CA (1) CA2175670C (pl)
CZ (1) CZ290186B6 (pl)
DE (2) DE4337573C1 (pl)
ES (1) ES2182846T3 (pl)
FI (1) FI116569B (pl)
HU (1) HU222087B1 (pl)
IL (1) IL111263A (pl)
MY (1) MY113294A (pl)
NO (1) NO317112B1 (pl)
PL (1) PL181725B1 (pl)
RU (1) RU2148411C1 (pl)
SK (1) SK284215B6 (pl)
UA (1) UA43855C2 (pl)
WO (1) WO1995012609A1 (pl)
ZA (1) ZA948667B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19618851C1 (de) * 1996-05-10 1997-07-24 Octapharma Ag Verfahren zur Eignungsprüfung von Faktor VIII-haltigen Proteinfraktionen
EP0885394B1 (de) * 1996-03-08 2000-08-16 Octapharma AG Verfahren zur eignungsprüfung von faktor viii-haltigen proteinfraktionen
ES2137878B1 (es) * 1997-12-01 2000-10-01 Grifols Grupo Sa Procedimiento de obtencion de un plasma humano atenuado de virus para uso terapeutico.
RU2253475C1 (ru) * 2004-02-02 2005-06-10 Общество с ограниченной ответственностью "Гемоцентр" Способ получения препарата фактора viii
RU2324495C1 (ru) * 2006-08-31 2008-05-20 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Способ получения препарата фактора свертывания viii крови человека
US8329871B2 (en) * 2008-06-24 2012-12-11 Octapharma Ag Process of purifying coagulation factor VIII
EP2652491B1 (en) 2010-12-15 2017-11-29 Baxalta GmbH Eluate collection using conductivity gradient

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
JPS62191042A (ja) * 1986-02-17 1987-08-21 Kanegafuchi Chem Ind Co Ltd 血液凝固第８因子吸着体およびそれを用いた血液凝固第８因子の精製法
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
CA2001720C (en) * 1988-10-31 2001-10-02 Randal A. Goffe Membrane affinity apparatus and purification methods related thereto
EP0367840B1 (de) * 1988-11-05 1993-02-03 Octapharma AG Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie
CH678155A5 (pl) * 1989-08-09 1991-08-15 Fischer Ag Georg
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation

Also Published As

Publication number Publication date
PL314185A1 (en) 1996-09-02
CA2175670C (en) 2005-08-02
DE59410213D1 (de) 2003-01-09
ES2182846T3 (es) 2003-03-16
DE4337573C1 (de) 1995-05-18
JP3739788B2 (ja) 2006-01-25
NO317112B1 (no) 2004-08-16
EP0726907B1 (de) 2002-11-27
FI961900A0 (fi) 1996-05-03
FI961900L (fi) 1996-05-03
UA43855C2 (uk) 2002-01-15
CA2175670A1 (en) 1995-05-11
HUT76530A (en) 1997-09-29
ATE228533T1 (de) 2002-12-15
SK284215B6 (sk) 2004-11-03
CZ290186B6 (cs) 2002-06-12
KR960705841A (ko) 1996-11-08
NO961816L (no) 1996-05-03
CN1109045C (zh) 2003-05-21
IL111263A (en) 2000-07-16
WO1995012609A1 (de) 1995-05-11
CN1134157A (zh) 1996-10-23
NO961816D0 (no) 1996-05-03
MY113294A (en) 2002-01-31
HU222087B1 (hu) 2003-04-28
EP0726907A1 (de) 1996-08-21
PL181725B1 (pl) 2001-09-28
RU2148411C1 (ru) 2000-05-10
JPH09504532A (ja) 1997-05-06
CZ118796A3 (en) 1996-12-11
AU7810994A (en) 1995-05-23
FI116569B (fi) 2005-12-30
AU687451B2 (en) 1998-02-26
IL111263A0 (en) 1994-12-29
SK56696A3 (en) 1996-10-02
HU9601192D0 (en) 1996-06-28

Similar Documents

Publication Publication Date Title
UA27732C2 (uk) Спосіб приготування стандартизованого концентрату фактору віллебранда людини та концентрат, одержаний цим способом
GR3003819T3 (pl)
AU580402B2 (en) Method of inactivating viruses involving adsorption on solid phase
EP0431129A4 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
DE359593T1 (de) Chromatographische trennung von plasmaproteinen.
DE69002395D1 (de) N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
BR9913026A (pt) Processo de purificação de partìculas semelhantes a vìrus (vlps) de papilomavìrus recombinante, e, processo de preparação de um produto de vlp de papilomavìrus humano purificado adequado para uso em uma vacina para humano
EP0680764A3 (en) Stable preparation for the treatment of blood coagulation disorders, comprising an activated coagulation factor and lipid vesicles
AU687451B2 (en) Process for producing a virus-inactivated factor VIII-containing fraction by chromatographic methods
ES2173927T3 (es) Procedimiento para la preparacion de un concentrado de inter-alfa-tripsina inhibidor de uso terapeutico, y concentrado obtenido.
AU561222B2 (en) Process for the pasteurization of human plasma
DK161590A (da) Fremgangsmaade til fremstilling af en meget ren ikke-infektioes antihaemofilifaktor ved hjaelp af kromatografi
GR3005036T3 (pl)
ZA949820B (en) Process for preparing agents containing virus-inactivated vitamin k-dependent plasma components as well as protein C and protein S by membrane chromatography
AU4948597A (en) Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use
ATE329602T1 (de) Verfahren zur herstellung von gereinigtem transferrin
MY118087A (en) A method for the aptitude testing of protein fractions containing factor viii
ES2138734T3 (es) Procedimiento para la preparacion de derivados de 1-(3-trialquilsililfenil)-2,2,2-trifluormetil etanona.
ES2117197T3 (es) Procedimiento para la extraccion y purificacion de alfa1-antitripsina (alfa1-pi) a partir de la fraccion de cohn iv-1.
ES2094701A1 (es) Procedimiento para la produccion de antitrombina iii
TW345599B (en) Nonwoven barrier and method making the same
GR1001635B (el) Μέ?οδος παρασκευής 3-[2-(διμε?υλαμινο)-αι?υλο]-ν-με?υλο-1η-ινδόλης-5-με?ανοσουλφοναμίδης.
UA13922A (uk) Спосіб одержаhhя коhтріhсуліhового фактора, який блокує зв'язуваhhя іhсуліhу з його рецептором та має діабетогеhhу дію
UA13921A (uk) Спосіб одержаhhя коhтррецепторhого фактора, який блокує зв'язуваhhя іhсуліhу з його рецептором та має діабетогеhhу дію